Belgium· BE-AMP-SAM573697-00
Respreeza 4000 mg
A alfa1 antitrypsin product containing alfa 1-proteinase inhibitor, registered in Belgium by CSL Behring. The same ATC class is registered in 11 of our 19 countries.
Checked against FAMHP / AFMPS (Belgium) on
Informational only — not a medical device.
Where it is registered
Alfa1 antitrypsin is registered in 11 of 19 countries.
Countries holding a registration under ATC B02AB02 (alfa1 antitrypsin), each read from that country’s own register.
- This record: Belgium, from FAMHP / AFMPS (Belgium)
- 7 of them publish a price we can compare per daily dose
Alfa1 antitrypsin · ATC B02AB02
11 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
Price per daily dose
What a daily dose of alfa1 antitrypsin costs, country by country.
Normalised to the WHO defined daily dose (0.6 g), so markets compare like for like.
- 1 market with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Alfa1 antitrypsin · price per daily dose (0.6 g)
USD · FX 28 Sept 2026
- CH Switzerland$261.83
The record
At a glance
FAMHP / AFMPS (Belgium)- Active substance
- Alfa 1-Proteinase inhibitor
- Manufacturer
- CSL Behring
- Country
- Belgium (BE)
- ATC code
- B02AB02
- ATC class
- Alfa1 antitrypsin
- Defined daily dose
- 0.6 g, P
- Reimbursed
- Not published by this register
- Source register
- FAMHP / AFMPS (Belgium)
- Last checked
- September 26, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same class
Other records under B02AB02
Alfa1 antitrypsin, as other registers publish it.
- SwitzerlandGlassia
- CanadaGLASSIATAKEDA CANADA INC
- SwitzerlandGlassia 20 mg/ml, InfusionslösungIDEOGEN AG
- PolandProlastinGrifols Deutschland GmbH
- SwitzerlandProlastin
- PolandProlastinGrifols Deutschland GmbH
- NetherlandsProlastin 1000 mg, poeder en oplosmiddel voor oplossing voor infusieGrifols Deutschland GmbH
- NetherlandsProlastin 4000 mg, poeder en oplosmiddel voor oplossing voor infusieGrifols Deutschland GmbH
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/e6330ff3-1fca-4dc6-b33f-3d93e513206b GET /v1/drugs/e6330ff3-1fca-4dc6-b33f-3d93e513206b?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Powder and solvent for solution for infusion",
"source": "afmps",
"status": "AUTHORIZED",
"name_en": "Respreeza 4000 mg",
"name_fr": "Respreeza 4000 mg",
"name_nl": "Respreeza 4000 mg",
"amp_code": "SAM573697-00",
"strengths": [
"4000.0000",
"1.9000"
],
"pack_count": 1,
"substances": [
"Alfa 1-Proteinase inhibitor",
"Mannitol",
"Sodium"
],
"medicine_type": "ALLOPATHIC",
"atc_description": "Alfa1 Antitrypsin",
"authorisation_numbers": [
"EU/1/15/1006/002"
]
}See everything about alfa1 antitrypsin.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.